17.07.2023 - NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) - The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2023 of $0.20 per Class A ordinary share. The dividend will be paid on .
17.10.2022 - NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) - The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2022 of $0.19 per Class A ordinary share. The dividend will be paid on .
18.04.2022 - NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) - The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2022 of $0.19 per Class A ordinary share. The dividend will be paid on June .
05.01.2022 - NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) - Royalty Pharma plc (Nasdaq: RPRX) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 8:15 a.m. ET. The webcast will be accessible .